Lyme borreliosis: A European perspective on diagnosis and clinical management

Current Opinion in Infectious Diseases

Volumn 22, Issue 5, 2009, Pages 450-454

  Stanek, Gerold ^a   Strle, Franc ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Diagnosis; Europe; Lyme borreliosis; Management

Indexed keywords

ANTIBIOTIC AGENT; CEFTRIAXONE; DOXYCYCLINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY;

ANTIBIOTIC THERAPY; ANTIGEN SPECIFICITY; BORRELIA BURGDORFERI; CLINICAL EVALUATION; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE CARRIER; DRUG EFFICACY; DRUG TARGETING; ECOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; LYME DISEASE; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; REVIEW; SEROLOGY;

BORRELIA BURGDORFERI; EUROPE; HUMANS; LYME DISEASE;

EID: 70249100304     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e32832ee880     Document Type: Review

References (30)

1. Strle F, Stanek G. Clinical manifestations and diagnosis of Lyme borreliosis. Curr Probl Dermatol 2009; 37:51-110.
2. Stanek G, Strle F. Lyme disease: European perspective. Infect Dis Clin North Am 2008; 22:327-339.
3. Stanek G, O?Connell S, Cimmino M, et al. European Union concerted action on risk assessment in Lyme borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996; 108:741-747.
4. Societe de Pathologie Infectieuse de Langue Francaise. Lyme borreliosis: diagnostic, therapeutic, and preventive approaches. Presse Med 2008; 37:1748-1755.
5. Flisiak R, Pancewicz S, Polish Society of Epidemiology and Infectious Diseases. Diagnostics and treatment of Lyme borreliosis. Recommendations of Polish Society of Epidemiology and Infectious Diseases. Przegl Epidemiol 2008; 62:193-199.
6. Gray JS, Dautel H, Estrada-Peña A, et al. Effects of climate change on ticks and tick-borne diseases in Europe. Interdiscip Perspect Infect Dis 2009; 2009:593232
7. Randolph SE. Tick-borne encephalitis virus, ticks and humans: short-term and long-term dynamics. Curr Opin Infect Dis 2008; 21:462-467.
8. Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E, et al. Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 2008; 298:279-290.
9. Dubska L, Literak I, Kocianova E, et al. Differential role of passerine birds in distribution of Borrelia spirochetes, based on data from ticks collected from birds during the postbreeding migration period in Central Europe. Appl Environ Microbiol 2009; 75:596-602.
10. Faulde MK, Robbins RG. Tick infestation risk and Borrelia burgdorferi s.l. infection-induced increase in host-finding efficacy of female Ixodes ricinus under natural conditions. Exp Appl Acarol 2008; 44:137-145.
11. Casati S, Bernasconi MV, Gern L, Piffaretti JC. Assessment of intraspecific mtDNA variability of European Ixodes ricinus sensu stricto (Acari: Ixodidae). Infect Genet Evol 2008; 8:152-158.
12. Schwarz A, Maier WA, Kistemann T, Kampen H. Analysis of the distribution of the tick Ixodes ricinus L. (Acari: Ixodidae) in a nature reserve of western Germany using Geographic Information Systems. Int J Hyg Environ Health 2009; 212:87-96.
13. Gassner F, Verbaarschot P, Smallegange RC, et al. Variations in Ixodesricinus density and borrelial infections associated with cattle introduced into a woodland in The Netherlands. Appl Environ Microbiol 2008; 74:7138-7144.
14. Ruzic-Sabljic E, Zore A, Strle F. Characterization of Borrelia burgdorferisensu lato isolates by pulsed-field gel electrophoresis after MluI restriction of genomic DNA. Res Microbiol 2008; 159:441-448.
15. Merljak Skocir L, Ruzic-Sabljic E, Maraspin-Carman V, et al. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans. Int J Med Microbiol 2008; 298:493-504.
16. Lencakova D, Fingerle V, Stefanćikova A, et al. Evaluation of recombinant line immunoblot for detection of Lyme disease in Slovakia: comparison with two other immunoassays. Vector Borne Zoonotic Dis 2008; 8:381-390.
17. Marangoni A, Moroni A, Accardo S, Cevenini R. Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis. Eur J Clin Microbiol Infect Dis 2008; 27:349-354.
18. Kraiczy P, Seling A, Brissette CA, et al. Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease. Clin Vaccine Immunol 2008; 15:484-491.
19. Stubs G, Fingerle V, Wilske B, et al. Acylated cholesteryl galactosides are specific antigens of Borrelia causing Lyme disease and frequently induce antibodies in late stages of disease. J Biol Chem 2009; 284: 13326-13334.
20. Glatz M, Fingerle V, Wilske B, et al. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans. Dermatology 2008; 216:93-103.
21. Cerar T, Ruzic-Sabljic E, Glinsek U, et al. Comparison of PCR methods and culture for the detection of Borrelia spp. in patients with erythema migrans. Clin Microbiol Infect 2008; 14:653-658. (Pubitemid 351837025)
22. Cerar T, Ogrinc K, Cimperman J, et al. Validation of cultivation and PCR methods for diagnosis of Lyme neuroborreliosis. J Clin Microbiol 2008; 46:3375-3379.
23. Skogman BH, Croner S, Forsberg P, et al. Improved laboratory diagnostics of Lyme neuroborreliosis in children by detection of antibodies to new antigens in cerebrospinal fluid. Pediatr Infect Dis J 2008; 27:605-612.
24. Ljøstad U, Mygland A. CSF B-lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 2008; 255:732-737.
25. Skogman BH, Croner S, Nordwall M, et al. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J 2008; 27:1089-1099.
26. Bennet R, Lindgren V, Zweygberg Wirgart B. Borrelia antibodies in children evaluated for Lyme neuroborreliosis. Infection 2008; 36:463-466.
27. Ljøstad U, Skogvoll E, Eikeland R, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, noninferiority, double-blind, randomised trial. Lancet Neurol 2008; 7:690-695.
28. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology 1994; 44:1203-1207.
29. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science 1993; 260:1610-1616.
30. Poggensee G, Fingerle V, Hunfeld KP, et al. Lyme borreliosis: research gaps and research approaches. Results from an interdisciplinary expert meeting at the Robert Koch Institute. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2008; 51:1329-1339.